封面
市場調查報告書
商品編碼
1945445

2026年全球微流體皮膚貼片市場報告

Lab-On-Skin Microfluidic Patch Global Market Report 2026

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來,皮膚貼片式實驗室微流體晶片市場呈指數級成長,預計將從2025年的14.4億美元成長到2026年的17.3億美元,複合年成長率達20.1%。這一成長可歸因於微流體技術的進步、穿戴式醫療技術的廣泛應用、運動分析的成長、對非侵入性診斷需求的增加以及生物流體分析研究的開展。

預計未來幾年,基於實驗室的皮膚微流體貼片市場將快速成長,到2030年市場規模將達到35.7億美元,複合年成長率(CAGR)為19.9%。預測期內的成長要素包括:與人工智慧驅動的分析技術的整合、個人化醫療的擴展、遠端患者監護的成長、健身和健康領域應用的日益廣泛,以及貼片材料的技術創新。預測期內的主要趨勢包括:持續健康監測、非侵入性診斷、個人化醫療設備、運動和健身分析以及即時生物標記檢測。

預計未來幾年,人們對個人化醫療日益成長的興趣將推動皮膚微流體貼片市場的擴張。個人化醫療是一種基於個人基因資訊、生物標記和臨床特徵客製化醫療方案和預防策略的醫療方法,旨在提高治療效果。基因組學和生物技術的進步推動了個人化醫療的日益普及,這些進步使得精準診斷和標靶治療成為可能,從而提高治療效果並減少不必要的干涉。皮膚微流體貼片透過持續監測獨特的生物標記,實現即時、個人化的治療決策,進而助力個人化醫療的發展。例如,根據美國非營利組織個人化醫療聯盟(PMC)2024年2月發布的消息,美國食品藥物管理局(FDA)在2023年核准了16種針對罕見疾病患者的新型個人化療法,較2022年的6種顯著增加。因此,人們對個人化醫療日益成長的興趣正在推動皮膚微流體貼片市場的成長。

在皮膚貼片實驗室微流體貼片市場運營的公司正在開發先進的微流體技術,例如汗液感測貼片,以支援即時健康監測和個人化診斷。汗液感測貼片是一種穿戴式設備,能夠收集和分析汗液,從而持續追蹤生物標記、電解質和其他生理指標。例如,總部位於美國的數位健康公司Epicore Biosystems Inc.於2024年4月推出了“Connected Hydration”,這是一款可與行動應用程式連接的穿戴式微流體流控貼片。它透過持續監測汗水和電解質,幫助工業工人預防脫水和中暑。它提供即時、個人化的補水資訊、振動警報和基於人工智慧的建議,以在疲勞或受傷發生之前最佳化液體攝取量。 「Connected Hydration」整合了皮膚貼片實驗室感測技術、雲端分析和長壽命電池系統,有助於提高全球工業領域在惡劣高溫環境下的工人安全、生產力和耐力。

目錄

第1章執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球皮膚微流體貼片市場:吸引力評分及分析
  • 成長潛力分析、競爭評估、策略契合度評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 主要原料、資源和供應商清單
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章 全球市場趨勢與策略

  • 關鍵技術和未來趨勢
    • 生物技術、基因組學和精準醫學
    • 人工智慧(AI)和自主人工智慧
    • 物聯網、智慧基礎設施和互聯生態系統
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
  • 主要趨勢
    • 持續健康監測
    • 非侵入性診斷
    • 個人化醫療器材
    • 運動與健身分析
    • 即時生物標記檢測

第5章 終端用戶產業市場分析

  • 醫院和診所
  • 居家醫療
  • 研究所
  • 運動健身中心
  • 老年人和慢性疾病患者

第6章 市場:宏觀經濟情景,包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響,以及新冠疫情對市場的影響

第7章 全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球皮膚微流體貼片市場:PESTEL 分析(政治、社會、技術、環境、法律因素、促進因素和限制因素)
  • 全球皮膚微流體貼片市場規模、對比及成長率分析
  • 全球皮膚微流體貼片市場表現:規模與成長,2020-2025年
  • 全球皮膚微流體貼片市場預測:規模與成長,2025-2030年,2035年預測

第8章 全球潛在市場規模(TAM)

第9章 市場細分

  • 依產品類型
  • 診斷補丁、監控補丁
  • 依材料類型
  • 聚合物基、混合及其他材料類型
  • 透過使用
  • 醫療保健監測、疾病診斷、運動健身及其他應用
  • 最終用戶
  • 醫院和診所、居家醫療、研究機構、體育和健身中心以及其他最終用戶
  • 按類型細分:診斷補丁
  • 基於汗液的微流體診斷貼片、組織液微流體診斷貼片、葡萄糖和代謝物檢測微流體貼片、電解質和生物標記分析微流體貼片、多成分分析型皮膚實驗室診斷貼片
  • 按類型細分:監控補丁
  • 用於連續水合狀態監測的微流體貼片、用於連續乳酸水平監測的微流體貼片、用於電解質平衡監測的微流體貼片、用於壓力和疲勞監測(基於生物化學)的微流體貼片、用於個性化健康監測的皮膚實驗室貼片

第10章 區域與國家分析

  • 全球皮膚微流體貼片市場:區域分析、預測及成長,2020-2025年、2025-2030年預測、2035年預測
  • 全球皮膚微流體貼片市場:依國家分類、績效及預測(2020-2025年、2025-2030年預測、2035年預測)

第11章 亞太市場

第12章:中國市場

第13章 印度市場

第14章 日本市場

第15章:澳洲市場

第16章 印尼市場

第17章 韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章:西歐市場

第21章英國市場

第22章 德國市場

第23章:法國市場

第24章:義大利市場

第25章:西班牙市場

第26章 東歐市場

第27章:俄羅斯市場

第28章 北美市場

第29章:美國市場

第30章:加拿大市場

第31章 南美洲市場

第32章:巴西市場

第33章 中東市場

第34章:非洲市場

第35章 市場監理與投資環境

第36章:競爭格局與公司概況

  • 皮膚微流體貼片市場:競爭格局及市場佔有率(2024年)
  • 皮膚微流體貼片市場:公司估值矩陣
  • 皮膚微流體貼片市場:公司概況
    • Epicore Biosystems
    • Xsensio SA
    • Persperity Health Inc.
    • Nutromics Pty Ltd.
    • Biolinq Inc.

第37章:其他領先和創新企業

  • Flow Bio Ltd., GraphWear Technologies Inc., GENTAG Inc., Nemaura Medical Inc., Kenzen Inc., Aline Inc., Eccrine Systems Inc., Nix Biosensors, Sonera, Zansors LLC, PointFit Technology Co. Ltd., Bitome Inc., Arma Biosciences, VivaLNK Inc., MC10 Inc.

第38章 全球市場競爭基準分析與儀錶板

第39章 重大併購

第40章:高潛力市場國家、細分市場與策略

  • 2030年皮膚微流體貼片市場:提供新機會的國家
  • 2030年皮膚微流體貼片市場:充滿新機會的細分市場
  • 2030年皮膚微流體貼片市場:成長策略
    • 基於市場趨勢的策略
    • 競爭對手策略

第41章附錄

簡介目錄
Product Code: ME4MLOSM01_G26Q1

A lab-on-skin microfluidic patch is a wearable device that combines microfluidic technology with a flexible, skin-adhering surface to continuously collect and analyze biofluids such as sweat, interstitial fluid, or tears. It operates as a compact laboratory on the skin, allowing real-time monitoring of physiological indicators such as electrolytes, glucose, lactate, and hydration levels for applications in health diagnostics, athletic performance, and personalized medicine.

The primary product types of lab-on-skin microfluidic patches include diagnostic patches, therapeutic patches, monitoring patches, and others. Diagnostic patches are skin-worn devices designed to detect and identify biomarkers such as ions, metabolites, or proteins that reflect disease states or physiological conditions. These patches are composed of materials such as polymer-based, paper-based, hybrid, and others. They are used in healthcare monitoring, disease diagnosis, drug delivery, sports and fitness, and other applications, serving end-users such as hospitals and clinics, homecare, research institutes, sports and fitness centers, and others.

Tariffs on microfluidic components and polymer substrates have affected the lab-on-skin microfluidic patch market, increasing costs of wearable diagnostic and therapeutic patches, especially in North America and Europe. However, this drives regional manufacturing initiatives and encourages innovation in alternative, cost-effective materials, supporting localized supply chains and market resilience.

The lab-on-skin microfluidic patch market research report is one of a series of new reports from The Business Research Company that provides lab-on-skin microfluidic patch market statistics, including lab-on-skin microfluidic patch industry global market size, regional shares, competitors with a lab-on-skin microfluidic patch market share, detailed lab-on-skin microfluidic patch market segments, market trends and opportunities, and any further data you may need to thrive in the lab-on-skin microfluidic patch industry. This lab-on-skin microfluidic patch market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The lab-on-skin microfluidic patch market size has grown exponentially in recent years. It will grow from $1.44 billion in 2025 to $1.73 billion in 2026 at a compound annual growth rate (CAGR) of 20.1%. The growth in the historic period can be attributed to advances in microfluidics, wearable healthcare technology adoption, growth of sports analytics, increasing demand for non-invasive diagnostics, research in biofluid analysis.

The lab-on-skin microfluidic patch market size is expected to see rapid growth in the next few years. It will grow to $3.57 billion in 2030 at a compound annual growth rate (CAGR) of 19.9%. The growth in the forecast period can be attributed to integration with AI-driven analytics, expansion in personalized medicine, remote patient monitoring growth, adoption in fitness & wellness sectors, technological innovation in patch materials. Major trends in the forecast period include continuous health monitoring, non-invasive diagnostics, personalized medicine devices, sports & fitness analytics, real-time biomarker detection.

The growing focus on personalized medicine is anticipated to drive the expansion of the lab-on-skin microfluidic patch market in the coming years. Personalized medicine is a healthcare approach that tailors medical treatment and preventive strategies to an individual's genetic, biomarker, and clinical profile to achieve better therapeutic outcomes. The increasing adoption of personalized medicine is supported by advances in genomics and biotechnology, which enable accurate diagnoses and targeted therapies that enhance treatment effectiveness and reduce unnecessary interventions. Lab-on-skin microfluidic patches contribute to this approach by continuously monitoring unique biomarkers, allowing real-time, individualized treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition (PMC), a US-based nonprofit organization promoting personalized medicine, the US Food and Drug Administration (FDA) approved 16 new personalized treatments for rare disease patients in 2023, compared to six approvals in 2022. Therefore, the rising emphasis on personalized medicine is propelling the growth of the lab-on-skin microfluidic patch market.

Companies operating in the lab-on-skin microfluidic patch market are increasingly developing advanced microfluidic technologies, such as sweat-sensing patches, to support real-time health monitoring and personalized diagnostics. A sweat-sensing patch is a wearable device that collects and analyzes sweat to track biomarkers, electrolytes, and other physiological indicators continuously. For example, in April 2024, Epicore Biosystems Inc., a US-based digital health company, launched Connected Hydration, a wearable microfluidic patch paired with a mobile application that helps industrial workers prevent dehydration and heat stress through continuous sweat and electrolyte monitoring. It offers real-time personalized hydration insights, vibration alerts, and AI-based recommendations to optimize fluid intake before fatigue or injury occurs. By integrating lab-on-skin sensing, cloud-based analytics, and a long-lasting battery system, Connected Hydration improves worker safety, productivity, and endurance in extreme heat environments across global industrial sectors.

In February 2024, Epicore Biosystems Inc. entered into a partnership with the US Anti-Doping Agency (USADA) to advance its microfluidic sweat patch technology for doping detection. This collaboration aims to enable non-invasive sweat biomarker collection for drug testing, improving the efficiency and convenience of anti-doping procedures while providing athletes with real-time health insights. The US Anti-Doping Agency is a US-based nonprofit and non-governmental organization responsible for implementing a comprehensive anti-doping program for ParaPan American sports in the United States.

Major companies operating in the lab-on-skin microfluidic patch market are Epicore Biosystems, Xsensio SA, Persperity Health Inc., Nutromics Pty Ltd., Biolinq Inc., Flow Bio Ltd., GraphWear Technologies Inc., GENTAG Inc., Nemaura Medical Inc., Kenzen Inc., Aline Inc., Eccrine Systems Inc., Nix Biosensors, Sonera, Zansors LLC, PointFit Technology Co. Ltd., Bitome Inc., Arma Biosciences, VivaLNK Inc., MC10 Inc., BioIntelliSense Inc.

North America was the largest region in the lab-on-skin microfluidic patch market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the lab-on-skin microfluidic patch market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the lab-on-skin microfluidic patch market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The lab-on-skin microfluidic patch market consists of sales of sensors, microfluidic chips, flexible substrates, electrodes, biosensors, hydrogels, and wearable bands. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Lab-On-Skin Microfluidic Patch Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses lab-on-skin microfluidic patch market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for lab-on-skin microfluidic patch ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The lab-on-skin microfluidic patch market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Product Type: Diagnostic Patches; Monitoring Patches
  • 2) By Material Type: Polymer-Based; Hybrid; Other Material Types
  • 3) By Application: Healthcare Monitoring; Disease Diagnosis; Sports And Fitness; Other Applications
  • 4) By End-User: Hospitals And Clinics; Homecare; Research Institutes; Sports And Fitness Centers; Other End-Users
  • Subsegments:
  • 1) By Diagnostic Patches: Sweat-Based Microfluidic Diagnostic Patches; Interstitial Fluid Microfluidic Diagnostic Patches; Glucose and Metabolite Detection Microfluidic Patches; Electrolyte and Biomarker Analysis Microfluidic Patches; Multi-Analyte Lab-on-Skin Diagnostic Patches
  • 2) By Monitoring Patches: Continuous Hydration Monitoring Microfluidic Patches; Continuous Lactate Monitoring Microfluidic Patches; Electrolyte Balance Monitoring Microfluidic Patches; Stress and Fatigue Monitoring Microfluidic Patches (Biochemical-Based); Personalized Health Monitoring Lab-on-Skin Patches
  • Companies Mentioned: Epicore Biosystems; Xsensio SA; Persperity Health Inc.; Nutromics Pty Ltd.; Biolinq Inc.; Flow Bio Ltd.; GraphWear Technologies Inc.; GENTAG Inc.; Nemaura Medical Inc.; Kenzen Inc.; Aline Inc.; Eccrine Systems Inc.; Nix Biosensors; Sonera; Zansors LLC; PointFit Technology Co. Ltd.; Bitome Inc.; Arma Biosciences; VivaLNK Inc.; MC10 Inc.; BioIntelliSense Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Lab-On-Skin Microfluidic Patch Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Lab-On-Skin Microfluidic Patch Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Lab-On-Skin Microfluidic Patch Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Lab-On-Skin Microfluidic Patch Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Industry 4.0 & Intelligent Manufacturing
  • 4.2. Major Trends
    • 4.2.1 Continuous Health Monitoring
    • 4.2.2 Non-Invasive Diagnostics
    • 4.2.3 Personalized Medicine Devices
    • 4.2.4 Sports & Fitness Analytics
    • 4.2.5 Real-Time Biomarker Detection

5. Lab-On-Skin Microfluidic Patch Market Analysis Of End Use Industries

  • 5.1 Hospitals & Clinics
  • 5.2 Homecare
  • 5.3 Research Institutes
  • 5.4 Sports & Fitness Centers
  • 5.5 Elderly & Chronic Disease Patients

6. Lab-On-Skin Microfluidic Patch Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Lab-On-Skin Microfluidic Patch Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Lab-On-Skin Microfluidic Patch PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Lab-On-Skin Microfluidic Patch Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Lab-On-Skin Microfluidic Patch Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Lab-On-Skin Microfluidic Patch Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Lab-On-Skin Microfluidic Patch Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Lab-On-Skin Microfluidic Patch Market Segmentation

  • 9.1. Global Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Diagnostic Patches, Monitoring Patches
  • 9.2. Global Lab-On-Skin Microfluidic Patch Market, Segmentation By Material Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Polymer-Based, Hybrid, Other Material Types
  • 9.3. Global Lab-On-Skin Microfluidic Patch Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Healthcare Monitoring, Disease Diagnosis, Sports And Fitness, Other Applications
  • 9.4. Global Lab-On-Skin Microfluidic Patch Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals And Clinics, Homecare, Research Institutes, Sports And Fitness Centers, Other End-Users
  • 9.5. Global Lab-On-Skin Microfluidic Patch Market, Sub-Segmentation Of Diagnostic Patches, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Sweat-Based Microfluidic Diagnostic Patches, Interstitial Fluid Microfluidic Diagnostic Patches, Glucose and Metabolite Detection Microfluidic Patches, Electrolyte and Biomarker Analysis Microfluidic Patches, Multi-Analyte Lab-on-Skin Diagnostic Patches
  • 9.6. Global Lab-On-Skin Microfluidic Patch Market, Sub-Segmentation Of Monitoring Patches, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Continuous Hydration Monitoring Microfluidic Patches, Continuous Lactate Monitoring Microfluidic Patches, Electrolyte Balance Monitoring Microfluidic Patches, Stress and Fatigue Monitoring Microfluidic Patches (Biochemical-Based), Personalized Health Monitoring Lab-on-Skin Patches

10. Lab-On-Skin Microfluidic Patch Market Regional And Country Analysis

  • 10.1. Global Lab-On-Skin Microfluidic Patch Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Lab-On-Skin Microfluidic Patch Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Lab-On-Skin Microfluidic Patch Market

  • 11.1. Asia-Pacific Lab-On-Skin Microfluidic Patch Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Lab-On-Skin Microfluidic Patch Market

  • 12.1. China Lab-On-Skin Microfluidic Patch Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Lab-On-Skin Microfluidic Patch Market

  • 13.1. India Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Lab-On-Skin Microfluidic Patch Market

  • 14.1. Japan Lab-On-Skin Microfluidic Patch Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Lab-On-Skin Microfluidic Patch Market

  • 15.1. Australia Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Lab-On-Skin Microfluidic Patch Market

  • 16.1. Indonesia Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Lab-On-Skin Microfluidic Patch Market

  • 17.1. South Korea Lab-On-Skin Microfluidic Patch Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Lab-On-Skin Microfluidic Patch Market

  • 18.1. Taiwan Lab-On-Skin Microfluidic Patch Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Lab-On-Skin Microfluidic Patch Market

  • 19.1. South East Asia Lab-On-Skin Microfluidic Patch Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Lab-On-Skin Microfluidic Patch Market

  • 20.1. Western Europe Lab-On-Skin Microfluidic Patch Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Lab-On-Skin Microfluidic Patch Market

  • 21.1. UK Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Lab-On-Skin Microfluidic Patch Market

  • 22.1. Germany Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Lab-On-Skin Microfluidic Patch Market

  • 23.1. France Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Lab-On-Skin Microfluidic Patch Market

  • 24.1. Italy Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Lab-On-Skin Microfluidic Patch Market

  • 25.1. Spain Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Lab-On-Skin Microfluidic Patch Market

  • 26.1. Eastern Europe Lab-On-Skin Microfluidic Patch Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Lab-On-Skin Microfluidic Patch Market

  • 27.1. Russia Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Lab-On-Skin Microfluidic Patch Market

  • 28.1. North America Lab-On-Skin Microfluidic Patch Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Lab-On-Skin Microfluidic Patch Market

  • 29.1. USA Lab-On-Skin Microfluidic Patch Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Lab-On-Skin Microfluidic Patch Market

  • 30.1. Canada Lab-On-Skin Microfluidic Patch Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Lab-On-Skin Microfluidic Patch Market

  • 31.1. South America Lab-On-Skin Microfluidic Patch Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Lab-On-Skin Microfluidic Patch Market

  • 32.1. Brazil Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Lab-On-Skin Microfluidic Patch Market

  • 33.1. Middle East Lab-On-Skin Microfluidic Patch Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Lab-On-Skin Microfluidic Patch Market

  • 34.1. Africa Lab-On-Skin Microfluidic Patch Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Lab-On-Skin Microfluidic Patch Market, Segmentation By Product Type, Segmentation By Material Type, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Lab-On-Skin Microfluidic Patch Market Regulatory and Investment Landscape

36. Lab-On-Skin Microfluidic Patch Market Competitive Landscape And Company Profiles

  • 36.1. Lab-On-Skin Microfluidic Patch Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Lab-On-Skin Microfluidic Patch Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Lab-On-Skin Microfluidic Patch Market Company Profiles
    • 36.3.1. Epicore Biosystems Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Xsensio SA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Persperity Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Nutromics Pty Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Biolinq Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Lab-On-Skin Microfluidic Patch Market Other Major And Innovative Companies

  • Flow Bio Ltd., GraphWear Technologies Inc., GENTAG Inc., Nemaura Medical Inc., Kenzen Inc., Aline Inc., Eccrine Systems Inc., Nix Biosensors, Sonera, Zansors LLC, PointFit Technology Co. Ltd., Bitome Inc., Arma Biosciences, VivaLNK Inc., MC10 Inc.

38. Global Lab-On-Skin Microfluidic Patch Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Lab-On-Skin Microfluidic Patch Market

40. Lab-On-Skin Microfluidic Patch Market High Potential Countries, Segments and Strategies

  • 40.1 Lab-On-Skin Microfluidic Patch Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Lab-On-Skin Microfluidic Patch Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Lab-On-Skin Microfluidic Patch Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer